Total Clarity Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-141
Closed -$6K 643
2022
Q2
$6K Buy
+141
New +$6.31K ﹤0.01% 783
2022
Q1
Sell
-129
Closed -$6K 602
2021
Q4
$6K Buy
129
+11
+9% +$569 ﹤0.01% 786
2021
Q3
$6K Buy
+118
New +$6.65K ﹤0.01% 785
2021
Q2
Sell
-118
Closed -$6K 492
2021
Q1
$6K Buy
+118
New +$5.53K ﹤0.01% 656

Other funds holding LMAT

Total Clarity Wealth Management's LMAT Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of LeMaitre Vascular (LMAT) in Q3 2022, closing a stake of 141 shares — an estimated $6K sold.

Total Clarity Wealth Management first reported a position in LMAT in Q1 2021 and held it in 4 quarters. The position peaked at $6K in Q2 2022. 189 funds tracked by Wall St. Rank hold LMAT as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining LeMaitre Vascular position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 141 LeMaitre Vascular shares in Q3 2022, an estimated $6K.
  • Total Clarity Wealth Management first reported a position in LeMaitre Vascular in Q1 2021 and held it in 4 quarters.
  • Total Clarity Wealth Management's LeMaitre Vascular position peaked at $6K in Q2 2022.
  • 189 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.